E. Ohman J or Asset Management AB reduced its position in Cigna Group (NYSE:CI – Free Report) by 17.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,450 shares of the health services provider’s stock after selling 2,008 shares during the period. E. Ohman J or Asset Management AB’s holdings in Cigna Group were worth $2,601,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Norges Bank bought a new stake in Cigna Group during the second quarter worth $1,110,426,000. Capital Research Global Investors grew its stake in Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after purchasing an additional 1,855,897 shares during the period. Ameriprise Financial Inc. increased its position in shares of Cigna Group by 54.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after purchasing an additional 753,865 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Cigna Group by 24.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after purchasing an additional 492,045 shares during the last quarter. Finally, Balyasny Asset Management L.P. raised its stake in shares of Cigna Group by 1,057.2% during the 2nd quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after purchasing an additional 369,775 shares during the period. Institutional investors own 86.99% of the company’s stock.
Cigna Group Trading Up 1.6%
NYSE:CI opened at $265.78 on Wednesday. The company has a market cap of $70.04 billion, a P/E ratio of 11.98, a P/E/G ratio of 0.91 and a beta of 0.27. The stock’s fifty day moving average price is $277.46 and its two-hundred day moving average price is $280.87. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74.
Cigna Group Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Thursday, March 5th. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is presently 28.13%.
Insider Activity
In other news, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.60% of the company’s stock.
Analysts Set New Price Targets
CI has been the topic of a number of research analyst reports. Robert W. Baird cut their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. UBS Group reiterated a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a research note on Monday, February 9th. Mizuho set a $325.00 target price on shares of Cigna Group in a research report on Friday, January 9th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $333.11.
View Our Latest Stock Report on CI
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Recommended Stories
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
